Please use this identifier to cite or link to this item:
|Title:||Factors affecting circuit patency and filter 'life'.|
|Affiliation:||Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia|
Department of Nursing and Health Sciences, RMIT University, Melbourne, Vic., Australia
|Citation:||Contributions To Nephrology; 156(): 178-84|
|Abstract:||Frequent clotting applying continuous renal replacement therapy means treatment can be inadequate and with increased costs for circuits and nursing time. Patency of the extracorporeal circuit is commonly achieved using anticoagulants such as heparin. When anticoagulants are not used, or clotting occurs within a few hours of use, with anticoagulation, blood flow failure is a likely cause. The blood pump can fail to deliver without operator awareness. Clotting within the membrane and/or venous 'air-trap' chamber is common where resistance to blood flow is high with stasis and turbulence. The design of the venous chamber allows the blood fill level to oscillate and form a clot, with a blood filter at the exit of the chamber also causing clot development. Several practices attempt to prevent clotting, however most without evidence. Adding heparin to the circuit during the preparation phase, ensuring that the access catheter is not obstructed, a blood flow setting of >or=200 ml/min, and administration of substitution fluids before the membrane (predilution) can be useful strategies for increasing circuit patency. An audit of filter life is useful and necessary feedback to nursing staff training strategies. This promotes safety and, when circuit patency is poor, may reflect poor troubleshooting ability.|
|Internal ID Number:||17464125|
|Subjects:||Acute Kidney Injury.physiopathology.therapy|
Blood Coagulation.drug effects
Regional Blood Flow.physiology
Renal Replacement Therapy.instrumentation.methods
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.